For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Foundation Medicine, Inc.

USPTO Granted Patents = 39

CIPO Patents = 2

EPO Patents = 17

Trademarks = 27

Forward Citations = 374

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Philip James Stephens (26 out of 26 patents)

Roman Yelensky (24 out of 31 patents)

Doron Lipson (21 out of 32 patents)

4. Matthew J Hawryluk (16 out of 16 patents)

5. Garrett Michael Frampton (12 out of 12 patents)

6. Vincent A Miller (10 out of 10 patents)

7. Alexander Nevin Parker (9 out of 9 patents)

8. Sean R Downing (8 out of 9 patents)

9. Jeffrey S Ross (7 out of 34 patents)

10. James Xin Sun (7 out of 8 patents)

11. Geoffrey Alan Otto (7 out of 18 patents)

12. Gary Palmer (6 out of 7 patents)

13. Jie He (6 out of 6 patents)

14. David Fabrizio (5 out of 5 patents)

15. Maureen T Cronin (5 out of 5 patents)

39 patents: Sort by Forward Citations

1. 12456541 - Analysis of genetic variants (2025-10-28),

2. 12378302 - Fusion molecules and uses thereof (2025-08-05),

3. 12334192 - Computer-implemented system and method for identifying similar patients (2025-06-17),

4. 12331128 - Therapeutic and diagnostic methods for cancer (2025-06-17),

5. 12274699 - Methods of treating cholangiocarcinoma (2025-04-14),

6. 12239648 - KIF5B-RET fusion molecules and uses thereof (2025-03-04),

7. 12180540 - Optimization of multigene analysis of tumor samples (2024-12-31),

8. 12116638 - Estrogen receptor mutations and uses thereof (2024-10-15),

9. 12087453 - System and method for outcome tracking and analysis (2024-09-10),

10. 11959141 - Multigene analysis of tumor samples (2024-04-16),

11. 11771698 - Methods of treating cholangiocarcinoma (2023-10-03),

12. 11766439 - Human papilloma virus as predictor of cancer prognosis (2023-09-26),

13. 11725247 - Methods of treating cancer (2023-08-15),

14. 11674962 - Therapeutic and diagnostic methods for cancer (2023-06-13),

15. 11578372 - NTRK1 fusion molecules and uses thereof (2023-02-14),

Foundation Medicine, Inc. is a leading precision medicine company dedicated to transforming cancer care by utilizing genomic analysis to enable personalized treatment approaches. Through its comprehensive genomic profiling assays, Foundation Medicine aims to help healthcare professionals make informed decisions about the best treatment options for their patients. With a strong focus on research, innovation, and collaboration, the company is committed to advancing precision medicine and improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#58 in Cambridge, MA

#497 in Massachusetts

#8,541 in US

#16,945 in the World

Cambridge, MA, United States of America

Foundation Medicine, Inc.

Forward Citations = 374

58 inventors:

Philip James Stephens (26 out of 26 patents)

Roman Yelensky (24 out of 31 patents)

Doron Lipson (21 out of 32 patents)

4. Matthew J Hawryluk (16 out of 16 patents)

5. Garrett Michael Frampton (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…